Document Detail


Epirubicin: Is it like doxorubicin in breast cancer? A clinical review.
MedLine Citation:
PMID:  22260846     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Anthracyclines are among the most effective chemotherapy treatments available for various types of cancer. The anthracyclines commonly used in treatment of breast cancer are either epirubicin or doxorubicin. Epirubicin is an epimer of doxorubicin with important role in the chemotherapy treatment of both early and metastatic breast cancer. The efficacy of epirubicin is similar to doxorubicin while epirubicin has a different toxicity profile particularly in regard to cardiotoxicity. Epirubicin has been incorporated into most of the anthracycline containing chemotherapy combinations in well-conducted clinical trials involving large numbers of patients. It has also been investigated in studies involving the administration of epirubicin in dose-dense chemotherapy schedules. Short term follow up of dose-dense clinical trials demonstrated safety comparable to that of doxorubicin. This review summarizes published clinical trials investigating epirubicin in the treatment of early and advanced breast cancer.
Authors:
Mustafa Khasraw; Richard Bell; Chau Dang
Related Documents :
22138966 - Diagnostic delay, quality of life and patient satisfaction among women diagnosed with e...
22202026 - Cancer stem cells and resistance to chemo and radio therapy.
21785976 - Expanding cancer prevention education to national and international audiences: the nati...
22078316 - Papillomavirus e5: the smallest oncoprotein with many functions.
23231516 - Cancer and heterogeneity of obesity: a potential contribution of brown fat.
7480286 - Complete elimination of large café-au-lait birthmarks by the 510-nm pulsed dye laser.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-17
Journal Detail:
Title:  Breast (Edinburgh, Scotland)     Volume:  -     ISSN:  1532-3080     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9213011     Medline TA:  Breast     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Andrew Love Cancer Center, Geelong Hospital, Australia; School of Medicine of Deakin University, Geelong VIC 3220, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Physical and chemical control of the phytoplankton of Ahe lagoon, French Polynesia.
Next Document:  Community-acquired methicillin resistant Staphylococcus aureus skin and soft tissue infections in Ma...